Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs

Scooter Willis, Pradip De, Nandini Dey, Bradley Long, Brandon Young, Joseph A. Sparano, Victoria Wang, Nancy E. Davidson, Brian R. Leyland-Jones

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs'. Together they form a unique fingerprint.

Medicine & Life Sciences